Bharat Biotech’s Covaxin Has 81% Efficacy. Here’s How it Compares to Serum Institute’s Covishield

By
-
0
180

Covaxin demonstrated 81 per cent interim efficacy in preventing Covid-19 in those without prior infection after the second dose, said the statement.